Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 9, 2015, Pages 2128-2135

  Zhu, Lingyin ^a,b   Ren, Lin ^a,c   Chen, Yingxuan ^a   Fang, Jingyuan ^a   Ge, Zhizheng ^a   Li, Xiaobo ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^c First People's Hospital of Lianyungang   (China)

Author keywords

All thiol form; Disulfide form; High mobility group box 1; Tumour angiogenesis; VEGF A

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; TOLL LIKE RECEPTOR 4; VASCULOTROPIN A; DISULFIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTIC RING ASSAY; ARTICLE; CELL INVASION ASSAY; CELL MIGRATION ASSAY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUBULAR FORMATION ASSAY; TUMOR MICROENVIRONMENT; UPREGULATION; WESTERN BLOTTING; ANIMAL; COCULTURE; COLORECTAL TUMOR; HCT 116 CELL LINE; IN VITRO STUDY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); OXIDATION REDUCTION REACTION; PATHOLOGY; SECRETION (PROCESS); SPRAGUE DAWLEY RAT; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

ANIMALS; COCULTURE TECHNIQUES; COLORECTAL NEOPLASMS; DISULFIDES; HCT116 CELLS; HMGB1 PROTEIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IN VITRO TECHNIQUES; NEOVASCULARIZATION, PATHOLOGIC; OXIDATION-REDUCTION; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84940788119     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12577     Document Type: Article

References (38)

1. Janko C, Filipović M, Munoz LE, et al. Redox modulation of HMGB1-related signaling. Antioxid Redox Signal. 2014; 20: 1075-85.
2. Venereau E, Casalgrandi M, Schiraldi M, et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med. 2012; 209: 1519-28.
3. Yang H, Lundbäck P, Ottosson L, et al. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med. 2012; 18: 250-9.
4. van Beijnum JR, Dings RP, van der Linden E, et al. Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature. Blood. 2006; 108: 2339-48.
5. Liu S, Stolz DB, Sappington PL, et al. HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers. Am J Physiol Cell Physiol. 2006; 290: C990-9.
6. Jube S, Rivera ZS, Bianchi ME, et al. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Res. 2012; 72: 3290-301.
7. Lee H, Park M, Shin N, et al. High mobility group box-1 is phosphorylated by protein kinase C zeta and secreted in colon cancer cells. Biochem Biophys Res Commun. 2012; 424: 321-6.
8. Choi YR, Kim H, Kang HJ, et al. Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation. Cancer Res. 2003; 63: 2188-93.
9. Kuniyasu H, Sasaki T, Sasahira T, et al. Depletion of tumor-infiltrating macrophages is associated with amphoterin expression in colon cancer. Pathobiology. 2004; 71: 129-36.
10. Mullins GE, Sunden-Cullberg J, Johansson AS, et al. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group boxchromosomal protein 1. Scand J Immunol. 2004; 60: 566-73.
11. van Beijnum JR, Nowak-Sliwinska P, van den Boezem E, et al. Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1. Oncogene. 2013; 32: 363-74.
12. van Beijnum JR, Buurman WA, Griffioen AW. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis. 2008; 11: 91-9.
13. Chaiswing L, Oberley TD. Extracellular/microenvironmental redox state. Antioxid Redox Signal. 2010; 13: 449-65.
14. Grek CL, Tew KD. Redox metabolism and malignancy. Curr Opin Pharmacol. 2010; 10: 362-8.
15. Kazama H, Ricci JE, Herndon JM, et al. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity. 2008; 29: 21-32.
16. Ushio-Fukai M, Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 2008; 266: 37-52.
17. Łuczak K, Balcerczyk A, Soszyński M, et al. Low concentration of oxidant and nitric oxide donors stimulate proliferation of human endothelial cells in vitro. Cell Biol Int. 2004; 28: 483-6.
18. Xia Y, Chen R, Song Z, et al. Gene expression profiles during activation of cultured rat hepatic stellate cells by tumoral hepatocytes and fetal bovine serum. J Cancer Res Clin Oncol. 2010; 136: 309-21.
19. Yang H, Hreggvidsdottir HS, Palmblad K, et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci USA. 2010; 107: 11942-7.
20. Qin S, Wang H, Yuan R, et al. Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med. 2006; 203: 1637-42.
21. Choi YS, Choi HJ, Min JK, et al. Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitricoxide production. Blood. 2009; 114: 3117-26.
22. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000; 6: 389-95.
23. Nagy JA, Dvorak AM, Dvorak HF. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol. 2007; 2: 251-75.
24. Kawahara K, Hashiguchi T, Kikuchi K, et al. Induction of high mobility group box 1 release from serotonin-stimulated human umbilical vein endothelial cells. Int J Mol Med. 2008; 22: 639-44.
25. Lee JJ, Hsiao CC, Yang IH, et al. High-mobility group box 1 protein is implicated in advanced glycation end products-induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5. Mol Vis. 2012; 18: 838-50.
26. Biscetti F, Straface G, De Cristofaro R, et al. High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes. 2010; 59: 1496-505.
27. Wake H, Mori S, Liu K, et al. Histidine-rich glycoprotein inhibited high mobility group box 1 in complex with heparin-induced angiogenesis in matrigel plug assay. Eur J Pharmacol. 2009; 623: 89-95.
28. Penzo M, Molteni R, Suda T, et al. Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis. J Immunol. 2010; 184: 4497-509.
29. Andrassy M, Volz HC, Igwe JC, et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation. 2008; 117: 3216-26.
30. Venereau E, Schiraldi M, Uguccioni M, et al. HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol Immunol. 2013; 55: 76-82.
31. Gaillard C, Borde C, Gozlan J, et al. A high-sensitivity method for detection and measurement of HMGB1 protein concentration by high-affinity binding to DNA hemicatenanes. PLoS ONE. 2008; 3: e2855.
32. Chavakis E, Hain A, Vinci M, et al. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res. 2007; 100: 204-12.
33. Mitola S, Belleri M, Urbinati C, et al. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol. 2006; 176: 12-5.
34. Sachdev U, Cui X, Hong G, et al. High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury. J Vasc Surg. 2012; 55: 180-91.
35. Luo Y, Ohmori H, Fujii K, et al. HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer. Eur J Cancer. 2010; 46: 791-9.
36. Zandarashvili L, Sahu D, Lee K, et al. Real-time kinetics of high-mobility group box 1 (HMGB1) oxidation in extracellular fluids studied by in situ protein NMR spectroscopy. J Biol Chem. 2013; 288: 11621-7.
37. Yang H, Antoine DJ, Andersson U, et al. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol. 2013; 93: 865-73.
38. Tang D, Kang R, Livesey KM, et al. High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress. Antioxid Redox Signal. 2011; 15: 2185-95.